KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Assets Average: 2011-2024

Historic Assets Average for TherapeuticsMD (TXMD) over the last 14 years, with Dec 2024 value amounting to $41.1 million.

  • TherapeuticsMD's Assets Average fell 3.14% to $38.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.6 million, marking a year-over-year decrease of 3.14%. This contributed to the annual value of $41.1 million for FY2024, which is 38.60% down from last year.
  • Per TherapeuticsMD's latest filing, its Assets Average stood at $41.1 million for FY2024, which was down 38.60% from $66.9 million recorded in FY2023.
  • In the past 5 years, TherapeuticsMD's Assets Average ranged from a high of $223.8 million in FY2020 and a low of $41.1 million during FY2024.
  • For the 3-year period, TherapeuticsMD's Assets Average averaged around $79.3 million, with its median value being $66.9 million (2023).
  • Data for TherapeuticsMD's Assets Average shows a maximum YoY tumbled of 48.54% (in 2023) over the last 5 years.
  • Over the past 5 years, TherapeuticsMD's Assets Average (Yearly) stood at $223.8 million in 2020, then declined by 21.56% to $175.5 million in 2021, then declined by 25.96% to $130.0 million in 2022, then plummeted by 48.54% to $66.9 million in 2023, then slumped by 38.60% to $41.1 million in 2024.